Home / Cryoneurolysis for Pain Relief

Cryoneurolysis for Pain Relief

A clinically practical, evidence-informed webpage

Cryoneurolysis is a neuroablative (nerve-targeting) procedure in which very low temperatures are applied directly to a peripheral nerve (or targeted sensory branches) to reduce pain. In many pain conditions, the goal is not permanent nerve destruction, but reversible axonal injury that provides months of analgesia while allowing eventual nerve recovery. cryoneurolysis-1

This page consolidates: (1) the fundamentals of neurolysis and nerve injury grades, (2) cryoneurolysis mechanism and procedural physics, (3) indications/contraindications and expected outcomes, and (4) a curated reference list—including published cryoneurolysis articles involving Gautam Das and colleagues.

1) What is “neurolysis” and where does cryoneurolysis fit?

Neurolysis broadly means ablation or functional interruption of a nerve to reduce pain (and sometimes spasticity). Common neurolytic methods include: cryoneurolysis-1

  • Surgical ablation
  • Chemical neurolysis (e.g., alcohol, phenol, glycerol, hypertonic saline)
  • Thermal ablation (e.g., radiofrequency ablation / RFA)
  • Cryoablation / cryoneurolysis
  • Mechanical methods (compression—less common in pain practice)

Key clinical concern: unintended nerve damage

All neurolytic methods can cause unwanted effects depending on which fibers are injured:

  • Motor fiber injury → weakness/paralysis
  • Touch fiber injury → numbness
  • Autonomic fiber injury → dysfunction (rare in typical peripheral targets, but clinically important)
  • Neuritis / deafferentation pain; “ectopic signals” and “cross-talk” phenomena after nerve injury cryoneurolysis-1

2) Nerve injury grades: why cryoneurolysis is always “reversible”

A practical way to understand cryoneurolysis is to map it to nerve injury grades (Sunderland-style concepts): cryoneurolysis-1

  • 1st degree (neuropraxia): conduction block only; recovery typically minutes to days
  • 2nd degree (axonotmesis): axon interrupted, connective tissue scaffolding intact; recovery weeks to months (sometimes longer)
  • 3rd–5th degree (neurotmesis/transection spectrum): disruption of internal scaffolding; regeneration uncertain; neuroma and neuropathic pain risk rises

Cryoneurolysis is clinically valued because—when properly performed—it tends to preserve the epineurium/perineurium, limiting neuroma risk and enabling regeneration. cryoneurolysis-1

3) Definitions: cryoablation vs cryoneurolysis vs cryoanalgesia

You will see three terms used differently across literature and industry: cryoneurolysis-1

  • Cryoneurolysis: targeted low-temperature application to a nerve to produce analgesia via controlled nerve injury
  • Cryoablation: broader term (often used in oncology) for tissue destruction using freezing
  • Cryoanalgesia: pain reduction by cold (sometimes used loosely; in interventional pain, typically implies a procedure-based freezing approach)

4) Brief history of clinical cryotherapy devices

Selected milestones commonly cited in cryotherapy history include: cryoneurolysis-1

  • 1899: early medical use of refrigerants
  • 1950: liquid nitrogen in medical treatments
  • 1961: cryoprobe reaching ~−190°C (liquid nitrogen-based systems)
  • 1967: CO₂/N₂O probe systems reaching about −70°C (device evolution toward procedural use)

5) Cryophysics in plain language

Most interventional cryoneurolysis systems use compressed gas (commonly nitrous oxide or carbon dioxide). When the gas expands rapidly through a small orifice at the probe tip, temperature drops significantly due to the Joule–Thomson effect. cryoneurolysis-1

Typical gases and approximate minima (device-dependent): cryoneurolysis-1

  • Carbon dioxide: ~−79°C
  • Nitrous oxide: ~−88°C

Lesion size (clinical implication)

Lesion geometry varies with probe gauge, tip design, freeze–thaw cycles, tissue characteristics, and proximity to heat sinks (blood flow). Slide-based ranges commonly quoted include lesion widths of a few millimeters up to >1 cm and lesion lengths that can extend several centimeters in some probe configurations. cryoneurolysis-1

6) How freezing reduces pain: mechanism of action

Cryoneurolysis causes cellular and microvascular injury through a sequence of events: cryoneurolysis-1

  1. Extracellular ice formation → osmotic gradient → cell dehydration/shrinkage
  2. Progression to intracellular ice crystals → organelle disruption
  3. Microvascular injury → coagulation cascade → ischemia-mediated damage
  4. During thawing, water influx can cause cell swelling and rupture

In nerves, the clinically relevant outcome is often temporary axonal disruption (axonotmesis) with preserved connective tissue scaffolding—supporting regeneration over time.

7) Advantages of cryoneurolysis (why clinicians choose it)

Commonly cited advantages include: cryoneurolysis-1

  • Reduced procedural/post-procedural pain compared with some heat-based methods
  • Ability to create tailored, overlapping lesions using one or multiple probes
  • Preservation of epineurium/perineurium relative to some heat/surgical injuries → potentially lower neuroma risk
  • Avoids systemic toxicity risks associated with chemical neurolysis
  • Regeneration is expected in many targets, often quoted as occurring over months (frequently described as ~6–24 months depending on nerve length, patient factors, and lesion characteristics)

8) Contraindications and precautions

Common contraindications/avoid situations include: cryoneurolysis-1

  • Local/systemic infection
  • Bleeding disorder or uncontrolled anticoagulation status (case-by-case risk assessment)
  • Cryoglobulinemia
  • Cold urticaria
  • Raynaud’s disease/phenomenon (risk of cold-induced vascular events)

9) Side effects and risks to discuss during consent

Most risks are shared with other percutaneous nerve procedures, plus cold-specific issues: cryoneurolysis-1

  • Bleeding, bruising
  • Infection
  • Temporary numbness or dysesthesia
  • Motor weakness (if motor fibers are affected or target selection is inappropriate)
  • Neuritis (uncommon, but possible)

Risk is minimized by accurate target selection, imaging guidance (ultrasound/fluoroscopy where appropriate), careful probe placement, and patient selection.

10) Indications: where cryoneurolysis is used in pain practice

Reported or commonly used targets include (not exhaustive): cryoneurolysis-1

  • Occipital nerve (headache/occipital neuralgia phenotypes)
  • Suprascapular nerve (selected shoulder pain conditions)
  • Medial branch nerves (facet-mediated pain in selected contexts)
  • Intercostal nerves (intercostal neuralgia, post-thoracotomy pain, postherpetic neuralgia in selected cases)
  • Ilioinguinal/iliohypogastric/genitofemoral nerves (groin/abdominal wall neuralgias)
  • Scar neuralgia / post-surgical cutaneous nerve pain
  • Sacroiliac joint (SIJ) pain—targeting the sensory innervation pattern
  • Cluneal nerve, genicular nerve (selected knee pain contexts)
  • Pudendal nerve (highly selective; careful risk–benefit)
  • Certain movement disorder/spasticity applications (specialist contexts)

11) SI joint pain: why cryoneurolysis is discussed as an alternative/adjunct

For sacroiliac joint pain (SIJP), intra-articular steroids can help but may be short-lived; RFA can also be effective but duration varies. Cryoneurolysis has been studied as an option with the intent of providing longer relief in selected patients.

A retrospective case-control study in SIJP reported outcomes comparing cryoneurolysis with intra-articular steroid, with cryoneurolysis showing more sustained responder proportions at follow-up in that dataset.
A technical description/case series has also been published describing ultrasound-guided SIJ cryoneurolysis and early outcomes.

12) Practical “what to expect” (patient-facing)

Before the procedure

  • Your clinician will confirm the pain generator and may use diagnostic blocks and/or imaging correlation to improve target accuracy.

During the procedure

  • Typically performed under sterile conditions, often with ultrasound guidance (and fluoroscopy in some protocols/targets).
  • You may feel pressure or brief discomfort, but many patients tolerate cryoneurolysis well.

After the procedure

  • Some soreness, bruising, or temporary numbness can occur.
  • Pain relief may begin quickly or evolve over days.
  • Duration varies by condition and nerve target; many protocols aim for months of benefit.

If pain returns

  • Because nerve regeneration is expected in many cases, pain may recur; repeat treatment or alternative strategies may be considered based on diagnosis.

References:

  1. Das G, Das S, Sahoo R, Shreyas S, Kanthi B, Sharma VS. Efficacy of cryoneurolysis versus intra-articular steroid in sacroiliac joint pain: A retrospective, case-control study. Indian J Anaesth. 2023;67(11):1004–1008.
  2. Sahoo RK, Das G, Pathak L, Dutta D, Roy C, Bhatia A. Cryoneurolysis of innervation to sacroiliac joints: technical description and initial results—A case series. 2021. PubMed
  3. Narayanapanicker V, Das G. Cryoneurolysis: Is it the Future of Neurolysis…? Journal on Recent Advances in Pain. 2019;5(3).
  4. Pathak L, Khan KJ, Das G. Cryoneurolysis for post-hysterectomy scar neuralgia: An innovative management approach. Journal on Recent Advances in Pain. 2019;5(3):83–84.
  5. Khan KJ, Kumar A, Das G. Cryoneurolysis of genitofemoral neuralgia: A case report. Journal on Recent Advances in Pain. 2019;5(3):92–94.
  6. Vairamuthu R, Das G, Das S, Gotur A. Ultrasound-guided cryoneurolysis of intercostal nerves for intercostal neuralgia. Journal on Musculoskeletal Ultrasound in Pain Medicine. 2023;8(1).
  7. Das R, Das G, Das S. Ultrasound-guided cryoneurolysis of intercostal nerve in postherpetic neuralgia: A case report. Journal on Musculoskeletal Ultrasound in Pain Medicine. 2023.

FAQ

Is cryoneurolysis the same as RFA?
No. RFA uses heat to denature neural tissue; cryoneurolysis uses freezing. Cryoneurolysis is often selected when a reversible axonal injury with preserved nerve scaffolding is desired. cryoneurolysis-1

How long does cryoneurolysis last?
Duration varies by nerve target and diagnosis; many protocols aim for months of relief, with eventual nerve regeneration expected in many cases. cryoneurolysis-1

Is it safe?
In appropriate patients, with correct target selection and image guidance, cryoneurolysis is widely considered a safe interventional option. Risks include bruising, infection, sensory changes, and (rarely) weakness or neuritis. cryoneurolysis-1

Who should not undergo cryoneurolysis?
Patients with infection, significant bleeding risk, cryoglobulinemia, cold urticaria, or Raynaud’s disease/phenomenon generally require avoidance or specialist-level risk assessment. cryoneurolysis-1